|
| |
Intercytex Intercytex is an emerging healthcare company developing and commercialising cell therapy products
for the woundcare and aesthetic medicine markets. Intercytex is using its proprietary expertise in cell therapy to develop products that harness the innate ability of human cells to regenerate and repair the body.
Intercytex has four products in development.
ICX-PRO, designed actively to stimulate repair in chronic wounds - in Phase III trials
ICX-SKN, being developed as a durable and robust skin replacement - due to start Phase I trials during 2006
ICX-RHY, a facial rejuvenation product - in Phase I trials
ICX-TRC, a hair regeneration product - about to commence Phase II trials
Intercytex commenced operations in 2000 and currently employs around 70 staff. In addition to its head office in Cambridge, UK, it has a GMP clinical production facility plus research and development laboratories in Manchester, UK. Additional laboratories are located in Boston, USA.
Intercytex’ shares were admitted for trading on the Alternative Investment Market of the London Stock Exchange on 1 February 2006 under the ticker symbol ICX.L.
| Contact Details: |
| St John's Innovation CentreCowley Road |
| Cambridge |
| Cambridgeshire |
| CB4 0WS |
| United Kingdom |
| Tel: | 44 (0)1223 421962 |
| Fax: | 44 (0)1223 421961 |
| Email: | mail@intercytex.com |
| WWW: | www.intercytex.net/
|
|
Loading...
|
Recent Publications by Intercytex: |  |
Hair follicle neogenesis induced by cultured human scalp dermal papilla cells.
AIM: To develop a method by which human hair follicle dermal papilla (DP)... | 19th September, 2009
| Intercytex Ltd, 175E New Boston Street, Woburn, MA 01801, USA.
| Regen Med. 2009 Sep;4(5):667-76.
DOI Direct Link |
Integration and persistence of an investigational human living skin equivalent (ICX-SKN) in human surgical wounds.
AIM: To present the first human clinical data on an investigational living... | 2nd June, 2009
| Intercytex Ltd, Innovation House, Manchester, UK.
| Regen Med. 2007 Jul;2(4):363-70.
DOI Direct Link |
Tissue engineering and cell-populated collagen matrices.
Tissue engineering seeks to produce living, three-dimensional cellular... | 28th April, 2009
| Intercytex Ltd,
| Methods Mol Biol. 2009;522:363-70.
DOI Direct Link |
Hair morphogenesis in vitro: formation of hair structures suitable for implantation.
AIM: To develop a construct through which implanted follicular cells will... | 15th November, 2008
| Intercytex, Innovation House, Crewe Road, Manchester, M23 9QR, UK.
| Regen Med. 2008 Sep;3(5):683-92.
DOI Direct Link |
A graft model for hair development.
Follicular cell implantation (FCI) is an experimental cell therapy for the... | 22nd July, 2008
| Intercytex Ltd, 175-E New Boston Street, Woburn, MA, USA.
| Exp Dermatol. 2008 Jun;17(6):512-8. Epub 2007 Dec 7.
DOI Direct Link |
→View more Intercytex research publications. |
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 3156 times since April 2007, the link to the organisation's website has been followed 258 times Recent Search Terms used to find this page: intercytex november 2009 | Intercytex nov 2009 phase iii | intercytex news november 2009 | intercytex publication hair | intercytex news november 2009 | intercytex november 2009 | intercytex hair nov 2009 | intercytex news november 2009 | intercytex | intercytex news 2009 | . Search for more companies in Cambridge Search for more companies in Cambridgeshire This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Intercytex |
